Find Acrivastine manufacturers, exporters & distributors on PharmaCompass

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

7 API Suppliers, 3 USDMF, 3 EU WC, 4 NDC API, 4 Listed Suppliers, $ API Reference Price

7 API Suppliers
3 USDMF
3 EU WC
4 NDC API
4 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

4 FDF Dossiers, 1 FDA Orange Book, 3 Listed Dossiers

4 FDF Dossiers
1 FDA Orange Book
3 Listed Dossiers

RELATED EXCIPIENT COMPANIES

6 DKSH, 1 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 4 ACG Worldwide, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 1 DFE Pharma, 1 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 3 Kerry, 3 Lonza Capsugel, 5 Microlex e.U, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 5 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

11 Fillers, Diluents & Binders, 9 Disintegrants & Superdisintegrants, 9 Lubricants & Glidants, 8 Empty Capsules, 7 Thickeners and Stabilizers, 6 Coating Systems & Additives, 5 Co-Processed Excipients, 5 Direct Compression, 3 Granulation, 2 Coloring Agents, 2 Controlled & Modified Release, 2 Film Formers & Plasticizers, 1 Emulsifying Agents, 1 Taste Masking

excipientsByApplications
11 Fillers, Diluents & Binders
9 Disintegrants & Superdisintegrants
9 Lubricants & Glidants
8 Empty Capsules
7 Thickeners and Stabilizers
6 Coating Systems & Additives
5 Co-Processed Excipients
5 Direct Compression
3 Granulation
2 Coloring Agents
2 Controlled & Modified Release
2 Film Formers & Plasticizers
1 Emulsifying Agents
1 Taste Masking

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

MARKET PLACE

3 APIs

marketPlace
3 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 6,576

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

46 RELATED EXCIPIENT COMPANIES

71EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 87848-99-5, Semprex, Acrivastin, Acrivastinum, Acrivastina, Bw 825c

Molecular Formula

C₂₂H₂₄N₂O₂

Molecular Weight

348.4 g/mol

InChI Key

PWACSDKDOHSSQD-IUTFFREVSA-N

FDA UNII

A20F9XAI7W

Acrivastine is a synthetic alkylamine with non-sedative antihistaminergic activity. Acrivastine competitively blocks the histamine H1 receptor and limits the typical allergic and anaphylactic responses, including bronchoconstriction, vasodilation, increased capillary permeability, and spasmodic contraction of gastrointestinal smooth muscle, caused by actions of histamine on bronchial, and gastrointestinal smooth muscles, and on capillaries. This drug also prevents histamine-induced pain and itching of the skin and mucous membranes. (NCI05)

Acrivastine is a Histamine-1 Receptor Antagonist. The mechanism of action of acrivastine is as a Histamine H1 Receptor Antagonist.

1 2D Structure

Acrivastine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid

2.1.2 InChI

InChI=1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+

2.1.3 InChI Key

PWACSDKDOHSSQD-IUTFFREVSA-N

2.1.4 Canonical SMILES

CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC(=N3)C=CC(=O)O

2.1.5 Isomeric SMILES

CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC(=N3)/C=C/C(=O)O

2.2 Other Identifiers

2.2.1 UNII

A20F9XAI7W

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Bw 825c

2. Bw-825c

3. Bw825c

4. Semprex

2.3.2 Depositor-Supplied Synonyms

1. 87848-99-5

2. Semprex

3. Acrivastin

4. Acrivastinum

5. Acrivastina

6. Bw 825c

7. Bw-825c

8. Bw A825c

9. Chebi:83168

10. (e)-6-((e)-3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic Acid

11. 2-propenoic Acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (e,e)-

12. A20f9xai7w

13. 2-propenoic Acid,3-[6-[(1e)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-,(2e)-

14. (e)-3-[6-[(e)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic Acid

15. Ncgc00182053-02

16. Acrivastinum [latin]

17. Acrivastina [spanish]

18. Acrivastine [usan:inn:ban]

19. (2e)-3-{6-[(1e)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic Acid

20. Acrivastine (usan/inn)

21. Unii-a20f9xai7w

22. (e)-6-((e)-3-(1-pyrrolidinyl-1-p-tolylpropenyl)-2-pyridinacrylsaeure

23. Acrivastine [mi]

24. Acrivastine [inn]

25. Dsstox_cid_2555

26. Acrivastine [usan]

27. Acrivastine [vandf]

28. Schembl4702

29. Acrivastine [mart.]

30. Chembl1224

31. Dsstox_rid_76625

32. Dsstox_gsid_22555

33. Acrivastine [who-dd]

34. Mls006010115

35. Bidd:gt0209

36. Bw270c

37. Dtxsid6022555

38. Acrivastine, >=98% (hplc)

39. Acrivastine [orange Book]

40. Hms3886e20

41. Bcp06189

42. Hy-b1510

43. Zinc3776633

44. Tox21_113015

45. Ac-912

46. Bdbm50487466

47. Benadryl Allgy Relief Plus Decongest

48. Mfcd00869830

49. S5718

50. Akos005067182

51. Semprex-d Component Acrivastine

52. Cs-6454

53. Db09488

54. Ncgc00182053-03

55. (2e)-3-{6-[(1e)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-en-1-yl]pyridin-2-yl}prop-2-enoic Acid

56. Acrivastine Component Of Semprex-d

57. As-14623

58. Smr004701250

59. Cas-87848-99-5

60. D02760

61. D70156

62. 848a995

63. A916142

64. Q342745

65. Sr-01000942220

66. Q-200590

67. Sr-01000942220-1

68. (e)-3-{6-[3-pyrrolidino-1-(4-tolyl)prop-1e-enyl]-2-pyridyl}acrylic Acid

69. 6-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic Acid

70. (e)-3-(6-((e)-3-(pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridin-2-yl)acrylic Acid

71. 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-

72. 2-propenoic Acid, 3-[6-[(1e)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-, (2e)-

2.4 Create Date

2005-09-16

3 Chemical and Physical Properties

Molecular Formula	C₂₂H₂₄N₂O₂
Molecular Weight	348.4 g/mol
XLogP3	1.6
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	6
Exact Mass	348.183778013 g/mol
Monoisotopic Mass	348.183778013 g/mol
Topological Polar Surface Area	53.4 Å²
Heavy Atom Count	26
Formal Charge	0
Complexity	514
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	2
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

For the relief of symptoms associated with seasonal allergic rhinitis such as sneezing, rhinorrhea, pruritus, lacrimation, and nasal congestion.

FDA Label

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Histamine H1 Antagonists, Non-Sedating

A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)

5.2 FDA Pharmacological Classification

5.2.1 Active Moiety

ACRIVASTINE

5.2.2 FDA UNII

A20F9XAI7W

5.2.3 Pharmacological Classes

Established Pharmacologic Class [EPC] - Histamine-1 Receptor Antagonist

5.3 ATC Code

R - Respiratory system

R06 - Antihistamines for systemic use

R06A - Antihistamines for systemic use

R06AX - Other antihistamines for systemic use

R06AX18 - Acrivastine

5.4 Absorption, Distribution and Excretion

Absorption

Acrivastine was absorbed rapidly from the combination capsule following oral administration and was as bioavailable as a solution of acrivastine. After administration of SEMPREX-D Capsules, maximum plasma acrivastine concentrations were achieved at 1.14 0.23 hour.

Route of Elimination

A mass balance study in 7 healthy volunteers showed that acrivastine is primarily eliminated by the kidneys. Over a 72-hour collection period, about 84% of the administered total radioactivity was recovered in urine and about 13% in feces, for a combined recovery of about 97%.

Volume of Distribution

0.46 0.05 L/kg

Clearance

2.9 0.7 mL/min/kg

5.5 Biological Half-Life

The mean terminal half-life for acrivastine was 1.9 0.3 hours following single oral doses and increased to 3.5 1.9 hours at steady state. The terminal half-life for the propionic acid metabolite was 3.8 1.4 hours.

API SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

01

Biophore India Pharmaceuticals Pvt L...

India

iPHEX India

Attending

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

India

Virtual Booth

Digital Content

Acrivastine

GDUFA

DMF Review : Complete

Rev. Date : 2015-12-15

Pay. Date : 2015-09-29

DMF Number : 29830

Submission : 2015-09-29

Status : Active

Type : II

02

Chongqing Huapont Pharmaceutical Co ...

China

CPHI Middle east

Not Confirmed

03

Sterling Pharma Solutions Ltd

India

CPHI Middle east

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

01

Azico Biophore India Pvt. Ltd

India

CPHI Middle east

Not Confirmed

02

Azico Biophore India Pvt. Ltd

India

CPHI Middle east

Not Confirmed

03

Micro Labs Limited

India

CPHI Middle east

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

01

Azico Biophore India Private Limite...

India

CPHI Middle east

Not Confirmed

02

Chongqing Huapont Pharmaceutical Co...

China

CPHI Middle east

Not Confirmed

03

Micro Labs Limited

India

CPHI Middle east

Not Confirmed

04

Sterling Pharma Solutions Limited

United Kingdom

CPHI Middle east

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

01

Biophore India Pharmaceuticals Pvt ...

India

Medlab Asia & Asia Health

Not Confirmed

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

India

Virtual Booth

Digital Content

Acrivastine

About the Company : Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-appro...

Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.

02

Chongqing Huapont Pharmaceutical

China

Medlab Asia & Asia Health

Not Confirmed

03

Globofarm International

India

Medlab Asia & Asia Health

Not Confirmed

04

Micro Labs Limited

India

Medlab Asia & Asia Health

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Export","activeIngredients":"ACRIVASTINE","year":"2021","qtr":"Q2","strtotime":1622399400,"product":"ACRIVASTINE (ACR5O20006 & ACR5O21001) - FAC INV. 715200626","address":"NO.27,RACE COURSE ROAD,BANGALORE","city":"KARNATAKA","supplier":"MICRO LABS LIMITED","supplierCountry":"INDIA","foreign_port":"BUDAPEST","customer":"EXTRACTUM PHARMA ZRT","customerCountry":"HUNGARY","quantity":"22.00","actualQuantity":"22","unit":"KGS","unitRateFc":"7274","totalValueFC":"157408.2","currency":"USD","unitRateINR":524092.96136363636,"date":"31-May-2021","totalValueINR":"11530045.15","totalValueInUsd":"157408.2","indian_port":"BANGALORE AIR","hs_no":"29420090","bill_no":"2115947","productDescription":"API","marketType":"REGULATED MARKET","country":"HUNGARY","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"NO.27,RACE COURSE ROAD,BANGALORE, KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"ACRIVASTINE","year":"2021","qtr":"Q2","strtotime":1622399400,"product":"ACRIVASTINE (ACR5O20006 & ACR5O21001) -","address":"NO.27,RACE COURSE ROAD,BANGALORE","city":"KARNATAKA","supplier":"MICRO LABS LIMITED","supplierCountry":"INDIA","foreign_port":"BUDAPEST,","customer":"EXTRACTUM PHARMA ZRT","customerCountry":"HUNGARY","quantity":"22.00","actualQuantity":"22","unit":"KGS","unitRateFc":"6000","totalValueFC":"157530.4","currency":"EUR","unitRateINR":524500,"date":"31-May-2021","totalValueINR":"11539000","totalValueInUsd":"157530.4","indian_port":"BANGALORE AIR","hs_no":"29420090","bill_no":"2105169","productDescription":"API","marketType":"REGULATED MARKET","country":"HUNGARY","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"NO.27,RACE COURSE ROAD,BANGALORE, KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648665000,"product":"ACRIVASTINE IH,BATCH NO:ACR5O22001,ACR5O","address":"NO 31, RACE COURSE ROAD BANGALORE Contact No: 919945641620","city":"BENGALURU","supplier":"MICRO LABS LIMITED","supplierCountry":"INDIA","foreign_port":"BUDAPEST,","customer":"EXTRACTUM PHARMA ZRT","customerCountry":"HUNGARY","quantity":"15.00","actualQuantity":"15","unit":"KGS","unitRateFc":"6000","totalValueFC":"96983","currency":"EUR","unitRateINR":492800,"date":"31-Mar-2022","totalValueINR":"7392000","totalValueInUsd":"96983","indian_port":"BANGALORE AIR","hs_no":"29420090","bill_no":"9373596","productDescription":"API","marketType":"REGULATED MARKET","country":"HUNGARY","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"NO 31, RACE COURSE ROAD BANGALORE Contact No: 919945641620, BENGALURU","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1687372200,"product":"ACRIVASTINE (BATCH NO:ACR5P23006,ACR5P23","address":"NO 31, RACE COURSE ROAD BANGALORE Contact No: 919945641620","city":"BENGALURU","supplier":"MICRO LABS LIMITED","supplierCountry":"INDIA","foreign_port":"BUDAPEST,","customer":"EXTRACTUM PHARMA ZRT","customerCountry":"HUNGARY","quantity":"13.09","actualQuantity":"13.088","unit":"KGS","unitRateFc":"6000","totalValueFC":"83215.4","currency":"EUR","unitRateINR":522616.11491442547,"date":"22-Jun-2023","totalValueINR":"6839999.712","totalValueInUsd":"83215.4","indian_port":"BANGALORE AIR","hs_no":"29333100","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"HUNGARY","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"NO 31, RACE COURSE ROAD BANGALORE Contact No: 919945641620, BENGALURU","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715365800,"product":"ACRIVASTINE WS","address":"NO 31, RACE COURSE ROAD,BANGALORE","city":"BENGALURU,KARNATAKA","supplier":"MICRO LABS LIMITED","supplierCountry":"INDIA","foreign_port":"BUDAPEST,","customer":"EXTRACTUM PHARMA ZRT","customerCountry":"HUNGARY","quantity":"0.40","actualQuantity":"0.4","unit":"KGS","unitRateFc":"2000","totalValueFC":"776.7","currency":"USD","unitRateINR":161852.67499999999,"date":"11-May-2024","totalValueINR":"64741.07","totalValueInUsd":"776.7","indian_port":"Bangalore Air","hs_no":"29420090","bill_no":"9806418","productDescription":"API","marketType":"REGULATED MARKET","country":"HUNGARY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"NO 31, RACE COURSE ROAD,BANGALORE, BENGALURU,KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717007400,"product":"ACRIVASTINE IH (ACR5P24007 (MFG DATE 11.2023 - EXP DATE 10.2028))(KG)(QTY- 31.577)TAX INV NO:715201332\/28.05.2024","address":"NO 31, RACE COURSE ROAD,BANGALORE","city":"BENGALURU,KARNATAKA","supplier":"MICRO LABS LIMITED","supplierCountry":"INDIA","foreign_port":"BUDAPEST,","customer":"EXTRACTUM PHARMA ZRT","customerCountry":"HUNGARY","quantity":"31.58","actualQuantity":"31.577","unit":"KGS","unitRateFc":"6000","totalValueFC":"202506","currency":"EUR","unitRateINR":534557.33603572217,"date":"30-May-2024","totalValueINR":"16879717","totalValueInUsd":"202506","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"1305307","productDescription":"API","marketType":"REGULATED MARKET","country":"HUNGARY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"NO 31, RACE COURSE ROAD,BANGALORE, BENGALURU,KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721068200,"product":"ACRIVASTINE, SL\/24\/ACI\/002, SL\/24\/ACI\/003, SL\/24\/ACI\/004, (KG) (QTY: 1.50) TAX INV NO: 715201365\/13.07.2024","address":"NO 31, RACE COURSE ROAD,BANGALORE","city":"BENGALURU,KARNATAKA","supplier":"MICRO LABS LIMITED","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"JOHNSON & JOHNSON\/ KENVUE","customerCountry":"UNITED STATES","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"4000","totalValueFC":"5694.8","currency":"USD","unitRateINR":317358,"date":"16-Jul-2024","totalValueINR":"476037","totalValueInUsd":"5694.8","indian_port":"Bangalore Air","hs_no":"29420090","bill_no":"2454423","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"NO 31, RACE COURSE ROAD,BANGALORE, BENGALURU,KARNATAKA","customerAddress":""}]